Guest Editor: Thierry Burnouf, Professor, Director of the Graduate Institute of Biomedical Materials and Tissue Engineering, and of the International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei
Preface
Annals of Blood special issue on plasma fractionation
Review Article
An overview of plasma fractionation
Mini-Review
A global initiative on local preparation of viral inactivated cryoprecipitate in developing countries
Role of the mini-pool cryoprecipitate technology for cost-saving and guarantee of local Factor VIII, Von Willebrand Factor and Fibrinogen product supply: Egypt experience
Review Article
Regulation of plasma for fractionation in the United States
Evidence-based clinical indications of plasma products and future prospects
Steps and challenges in the implementation of a plasma fractionation program: Brazil experience
Building blocks of the viral safety margins of industrial plasma products
The organization of transfusion and fractionation in France and its regulation
Indian plasma fractionation industry: challenges and opportunities
Plasma fractionation in South Africa: challenges and successes in meeting international standards
Original Article
Perspective
Role of the quality assurance person in the production of recovered plasma for fractionation
Factor VIII manufactured from plasma—the ups and downs, and the up again: a personal journey—part 1: history of the development of plasma-derived factor VIII therapies
Factor VIII manufactured from plasma—the ups and downs, and the up again: a personal journey—part 2: aspects of factor VIII manufacture from plasma
Recent market status and trends of fractionated plasma products
Plasma fractionation in China: progress and challenges
Disclosure:
The series “Plasma Fractionation” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. Thierry Burnouf served as the unpaid Guest Editor for the series.